Financial toxicity - An overlooked side effect.
作者信息
Liang Margaret I, Huh Warner K
机构信息
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, United States.
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, United States.
出版信息
Gynecol Oncol. 2018 Jul;150(1):3-6. doi: 10.1016/j.ygyno.2018.05.012. Epub 2018 May 31.
Abstract
摘要
相似文献
1
Financial toxicity - An overlooked side effect.
Gynecol Oncol. 2018 Jul;150(1):3-6. doi: 10.1016/j.ygyno.2018.05.012. Epub 2018 May 31.
2
Financial toxicity in gynecologic oncology.
Gynecol Oncol. 2019 Jul;154(1):8-12. doi: 10.1016/j.ygyno.2019.04.003. Epub 2019 Apr 30.
3
Crowdsourcing to measure financial toxicity in gynecologic oncology.
Gynecol Oncol. 2021 May;161(2):595-600. doi: 10.1016/j.ygyno.2021.01.040. Epub 2021 Feb 5.
4
Extensive financial hardship among gynecologic cancer patients starting a new line of therapy.
Gynecol Oncol. 2020 Feb;156(2):271-277. doi: 10.1016/j.ygyno.2019.11.022. Epub 2019 Nov 23.
5
Out-of-pocket expenditures and the financial burden of healthcare among older adults: by nativity and length of residence in the United States.
J Gerontol Soc Work. 2015;58(2):149-70. doi: 10.1080/01634372.2014.943447. Epub 2014 Dec 22.
6
Financial toxicity: Ethical considerations for nurses.
Nursing. 2019 Oct;49(10):18-20. doi: 10.1097/01.NURSE.0000577692.18934.ff.
7
Marked variation in out-of-pocket costs for cancer care in Western Australia.
Med J Aust. 2020 Jun;212(11):525-526. doi: 10.5694/mja2.50590. Epub 2020 Apr 20.
8
Financial burden of healthcare for cancer patients with social medical insurance: a multi-centered study in urban China.
Int J Equity Health. 2017 Oct 10;16(1):180. doi: 10.1186/s12939-017-0675-y.
9
The importance of out-of-pocket cost information in the era of financial toxicity of cancer care.
Support Care Cancer. 2021 Mar;29(3):1149. doi: 10.1007/s00520-020-05526-6. Epub 2020 May 16.
10
Non-dialysis dependent chronic kidney disease is associated with high total and out-of-pocket healthcare expenditures.
BMC Nephrol. 2017 Jan 5;18(1):3. doi: 10.1186/s12882-016-0432-2.
引用本文的文献
1
A Financial Toxicity Screening and Care Coordination Quality Improvement Program in a Gynecology Oncology Urban Practice.
J Adv Pract Oncol. 2024 Jan;15(1):16-27. doi: 10.6004/jadpro.2024.15.1.2. Epub 2024 Jan 1.
2
Prior authorization for FDA-approved PARP inhibitors in ovarian cancer.
Gynecol Oncol Rep. 2024 Feb 13;52:101335. doi: 10.1016/j.gore.2024.101335. eCollection 2024 Apr.
3
Determination of a cut-off COmprehensive Score for financial Toxicity (COST) for identifying cost-related treatment nonadherence and impaired health-related quality of life among Chinese patients with cancer.
Support Care Cancer. 2024 Jan 27;32(2):136. doi: 10.1007/s00520-024-08320-w.
4
Economic hardships from COVID-19 and its association with socioeconomic factors and diabetes management indicators: A cross-sectional study.
Heliyon. 2022 May 18;8(5):e09461. doi: 10.1016/j.heliyon.2022.e09461. eCollection 2022 May.
5
Impact of Cost Conversation on Decision-Making Outcomes.
Mayo Clin Proc Innov Qual Outcomes. 2021 Jun 12;5(4):802-810. doi: 10.1016/j.mayocpiqo.2021.05.006. eCollection 2021 Aug.
6
Burden of Treatment among Elderly Patients with Cancer: A Scoping Review.
Healthcare (Basel). 2021 May 19;9(5):612. doi: 10.3390/healthcare9050612.
7
Measuring Financial Distress and Quality of Life Over Time in Patients With Gynecologic Cancer-Making the Case to Screen Early in the Treatment Course.
JCO Oncol Pract. 2021 Oct;17(10):e1576-e1583. doi: 10.1200/OP.20.00907. Epub 2021 Feb 17.
8
Financial toxicity: An adverse effect worthy of a black box warning?
Gynecol Oncol. 2020 Feb;156(2):263-264. doi: 10.1016/j.ygyno.2020.01.016.
9
Society of gynecologic oncology future of physician payment reform task force: Lessons learned in developing and implementing surgical alternative payment models.
Gynecol Oncol. 2020 Mar;156(3):701-709. doi: 10.1016/j.ygyno.2019.12.036. Epub 2020 Jan 6.
10
Extensive financial hardship among gynecologic cancer patients starting a new line of therapy.
Gynecol Oncol. 2020 Feb;156(2):271-277. doi: 10.1016/j.ygyno.2019.11.022. Epub 2019 Nov 23.
本文引用的文献
1
The financial burden and distress of patients with cancer: Understanding and stepping-up action on the financial toxicity of cancer treatment.
CA Cancer J Clin. 2018 Mar;68(2):153-165. doi: 10.3322/caac.21443. Epub 2018 Jan 16.
2
Cancer care delivery research in gynecologic oncology.
Gynecol Oncol. 2018 Mar;148(3):445-448. doi: 10.1016/j.ygyno.2017.12.027. Epub 2018 Jan 10.
3
Association of Patient Out-of-Pocket Costs With Prescription Abandonment and Delay in Fills of Novel Oral Anticancer Agents.
J Clin Oncol. 2018 Feb 10;36(5):476-482. doi: 10.1200/JCO.2017.74.5091. Epub 2017 Dec 20.
4
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet. 2017 Oct 28;390(10106):1949-1961. doi: 10.1016/S0140-6736(17)32440-6. Epub 2017 Sep 12.
5
Discussing Health Care Expenses in the Oncology Clinic: Analysis of Cost Conversations in Outpatient Encounters.
J Oncol Pract. 2017 Nov;13(11):e944-e956. doi: 10.1200/JOP.2017.022855. Epub 2017 Aug 23.
6
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet Oncol. 2017 Sep;18(9):1274-1284. doi: 10.1016/S1470-2045(17)30469-2. Epub 2017 Jul 25.
7
Patient Financial Assistance Programs: A Path to Affordability or a Barrier to Accessible Cancer Care?
J Clin Oncol. 2017 Jul 1;35(19):2113-2116. doi: 10.1200/JCO.2016.71.7280. Epub 2017 May 1.
8
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.
N Engl J Med. 2016 Dec 1;375(22):2154-2164. doi: 10.1056/NEJMoa1611310. Epub 2016 Oct 7.
9
The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
JAMA. 2016;316(8):858-71. doi: 10.1001/jama.2016.11237.
10
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received.
J Clin Oncol. 2016 Aug 20;34(24):2925-34. doi: 10.1200/JCO.2016.68.2518. Epub 2016 May 31.
Zotero 插件